Literature DB >> 34245589

Resources, methods, and data infrastructure to promote research in dementia care, caregiving, and services.

K Joanne Pike1, Sam Fazio1, Julie P W Bynum2, Thomas G Travison3, David Wendler4, Vincent Mor5.   

Abstract

BACKGROUND: The National Institute on Aging, in conjunction with the Department of Health and Human Services as part of the National Alzheimer's Project Act, hosted a 2020 Dementia Care, Caregiving, and Services Research Summit Virtual Meeting Series on August 13, 2020. This article reflects three presentations related to Theme 6: Research Resources, Methods, and Data Infrastructure. Dr. Bynum discussed the challenges of identifying people for population- and healthcare-based research, including how definitions of dementia have changed over time, the opportunities and challenges inherent in the use of electronic data sources, and the need to fit data collection strategies to research goals and questions. Dr. Travison provided an overview on the growing use of embedded pragmatic clinical trials (ePCTs) and how to enhance their impact in dementia research. Dr. Wendler presented on the ethical considerations relevant to consent for dementia research, including assessment of decisional capacity and the role of decisional surrogates.
CONCLUSIONS: The availability of claims data, electronic health records, and other sources of "existing" data has made the use and development of ePCTs both easier and more appealing. Among other things, they offer advantages in terms of lower cost and generalizability to real-world settings. This is turn has necessitated the use of informatic and analytic approaches to account for some of the limitations and complexities of such data, including multilevel clustering and the need to link and jointly analyze data from the person with dementia and those of their care partner. As part of this process, it will be important to broaden the scope of who is assessed for decisional capacity, make those assessments more study specific, and assist surrogates in making decisions based on what the individual would have chosen for themselves if capacitated (i.e., substituted judgment).
© 2021 The American Geriatrics Society.

Entities:  

Keywords:  Alzheimer's disease; decisional capacity; dementia; embedded pragmatic trials; healthcare generated data

Mesh:

Year:  2021        PMID: 34245589      PMCID: PMC8351358          DOI: 10.1111/jgs.17339

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  17 in total

Review 1.  Can we ensure that all research subjects give valid consent?

Authors:  David Wendler
Journal:  Arch Intern Med       Date:  2004-11-08

Review 2.  Recommendations for optimal ICD codes to study neurologic conditions: a systematic review.

Authors:  Christine St Germaine-Smith; Amy Metcalfe; Tamara Pringsheim; Jodie Irene Roberts; Cynthia A Beck; Brenda R Hemmelgarn; Jane McChesney; Hude Quan; Nathalie Jette
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

3.  Misidentification of Dementia in Medicare Claims and Related Costs.

Authors:  Carolyn W Zhu; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2018-10-13       Impact factor: 5.562

4.  Public's approach to surrogate consent for dementia research: cautious pragmatism.

Authors:  Raymond De Vries; Kerry A Ryan; Aimee Stanczyk; Paul S Appelbaum; Laura Damschroder; David S Knopman; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-12       Impact factor: 4.105

5.  Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research.

Authors:  Jason Karlawish; Jonathan Rubright; David Casarett; Mark Cary; Thomas Ten Have; Pamela Sankar
Journal:  Am J Psychiatry       Date:  2008-10-15       Impact factor: 18.112

6.  Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.

Authors:  R Dukoff; T Sunderland
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

7.  The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.

Authors:  Donald H Taylor; Truls Østbye; Kenneth M Langa; David Weir; Brenda L Plassman
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

Authors:  Scott Y H Kim; Paul S Appelbaum; Jeffrey Swan; T Scott Stroup; Joseph P McEvoy; Donald C Goff; Dilip V Jeste; J Steven Lamberti; Adrian Leibovici; Eric D Caine
Journal:  Br J Psychiatry       Date:  2007-07       Impact factor: 9.319

Review 9.  Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis.

Authors:  Linda Lang; Angela Clifford; Li Wei; Dongmei Zhang; Daryl Leung; Glenda Augustine; Isaac M Danat; Weiju Zhou; John R Copeland; Kaarin J Anstey; Ruoling Chen
Journal:  BMJ Open       Date:  2017-02-03       Impact factor: 2.692

10.  How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.

Authors:  Bridget Gaglio; Siobhan M Phillips; Suzanne Heurtin-Roberts; Michael A Sanchez; Russell E Glasgow
Journal:  Implement Sci       Date:  2014-08-28       Impact factor: 7.327

View more
  1 in total

1.  Analyses and identification of ICD codes for dementias in the research based on the NHIRD: a scoping review protocol.

Authors:  Ying-Jyun Shih; Jiun-Yi Wang; Ya-Hui Wang; Rong-Rong Shih; Yung-Jen Yang
Journal:  BMJ Open       Date:  2022-08-10       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.